Insulin aspart(Jiangsu Chia Tai-Tianqing Pharmaceutical)

门冬胰岛素(正大天晴)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin aspart(Jiangsu Chia Tai-Tianqing Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A